Abstract
863P Safety and efficacy of four courses of pembrolizumab combined with carboplatin and albumin-binding paclitaxel versus two courses of neoadjuvant therapy in patients with resectable head and neck squamous cell carcinoma: An optimal efficacy study (prospective, two-arm, phase II)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have